查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522996

呼吸障碍治疗药物市场报告：2030 年趋势、预测与竞争分析

Breathing Disorder & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

治疗呼吸疾病药物的趋势和预测

预计 2024 年至 2030 年，全球呼吸系统疾病治疗药物市场将以 15.6% 的复合年增长率成长。该市场的主要驱动力是人口中气喘盛行率的增加以及导致呼吸问题的过敏反应发生率的增加。全球呼吸系统疾病药物市场的未来充满希望，医院、诊所、零售药局和线上药局市场都有机会。

呼吸障碍治疗药物按细分市场

其中包括按类型、适应症、最终用途和地区分類的全球呼吸系统疾病治疗市场的预测。

呼吸障碍治疗药物市场洞察

Lucintel 预测，由于呼吸道感染疾病和疾病的增加，抗生素将在预测期内经历最高的增长。

在这个市场中，医院将继续成为最大的细分市场，因为它们的目标是提供专门的护理和药物。

由于老年人口的增长和呼吸道疾病发病率的上升，预计北美在预测期内将经历最高的增长。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球呼吸系统疾病治疗药物市场预计将以15.6%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动因素是人群中气喘盛行率的增加以及导致呼吸问题的过敏反应发生率的增加。

Q3.市场的主要细分市场是：

A3. 呼吸系统疾病药物市场前景广阔，医院、诊所、零售药局和网路药局市场都有机会。

Q4.市场的主要企业是：

A4.主要企业如下：

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis

Q5.未来最大的细分市场是什么？

A5.Lucintel 预测，由于呼吸道感染疾病和疾病的增加，抗生素将在预测期内出现最高增长。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于人口老化加剧和呼吸道疾病发生率增加，预计北美地区在预测期内将出现最高增长。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球呼吸系统疾病治疗药物市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球呼吸系统疾病治疗药物市场趋势（2018-2023）与预测（2024-2030）
  • 全球呼吸系统疾病药物市场（按类型）
    • 抗生素
    • 非类固醇消炎剂(NSAID)
    • 止咳药
    • 鼻减充血剂
    • 其他的
  • 全球呼吸系统疾病药物市场（按适应症）
    • 慢性阻塞性肺病（COPD）
    • 气喘
    • 过敏性鼻炎
    • 肺动脉高压
    • 囊肿纤维化（CF）
    • 特发性肺纤维化
    • 其他的
  • 全球呼吸系统疾病治疗药物市场（依最终用途）
    • 医院和诊所
    • 零售药房
    • 网路药房

第四章 2018-2030年区域市场趋势及预测分析

  • 全球呼吸系统疾病治疗药物市场（按地区）
  • 北美呼吸系统疾病治疗药物市场
  • 欧洲呼吸系统疾病治疗药物市场
  • 亚太地区呼吸系统疾病药物市场
  • 其他区域呼吸系统疾病治疗药物市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球呼吸系统疾病药物市场按类型分類的成长机会
    • 全球呼吸系统疾病治疗市场成长机会（按适应症）
    • 全球呼吸系统疾病治疗药物市场成长机会（依最终用途）
    • 全球呼吸系统疾病治疗药物市场成长机会（按地区）
  • 全球呼吸系统疾病治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球呼吸系统疾病治疗市场的产能
    • 全球呼吸系统疾病治疗市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis
简介目录

Breathing Disorder & Treatment Trends and Forecast

The future of the global breathing disorder & treatment market looks promising with opportunities in the hospital, clinic, retail pharmacy, and online pharmacy markets. The global breathing disorder & treatment market is expected to grow with a CAGR of 15.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of asthma among the population and rising allergic reaction that causes breathing problem.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Breathing Disorder & Treatment by Segment

The study includes a forecast for the global breathing disorder & treatment by type, indication, end use, and region.

Breathing Disorder & Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antibiotics
  • Non-Steroidal Anti-Inflammatory Drug (NSAIDs)
  • Cough Suppressant
  • Nasal Decongestant
  • Others

Breathing Disorder & Treatment Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Allergic Rhinitis
  • Pulmonary Hypertension
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis
  • Others

Breathing Disorder & Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital and Clinics
  • Retail Pharmacies
  • Online Pharmacies

Breathing Disorder & Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breathing Disorder & Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breathing disorder & treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breathing disorder & treatment companies profiled in this report include-

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis

Breathing Disorder & Treatment Market Insights

Lucintel forecasts that antibiotic is expected to witness the highest growth over the forecast period due to rising respiratory infections and disorders.

Within this market, hospital will remain the largest segment as it aims at providing specialized care and medications.

North America is expected to witness the highest growth over the forecast period due to increasing geriatric population and rising cases of respiratory disorders in the region.

Features of the Global Breathing Disorder & Treatment Market

Market Size Estimates: Breathing disorder & treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breathing disorder & treatment market size by type, indication, end use, and region in terms of value ($B).

Regional Analysis: Breathing disorder & treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, indication, end uses, and regions for the breathing disorder & treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breathing disorder & treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for breathing disorder & treatment market?

Answer: The global breathing disorder & treatment market is expected to grow with a CAGR of 15.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the breathing disorder & treatment market?

Answer: The major drivers for this market are increasing prevalence of asthma among the population and rising allergic reaction that causes breathing problem.

Q3. What are the major segments for breathing disorder & treatment market?

Answer: The future of the breathing disorder & treatment market looks promising with opportunities in the hospital, clinic, retail pharmacy, and online pharmacy markets.

Q4. Who are the key breathing disorder & treatment market companies?

Answer: Some of the key breathing disorder & treatment companies are as follows:

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis

Q5. Which breathing disorder & treatment market segment will be the largest in future?

Answer: Lucintel forecasts that antibiotic is expected to witness the highest growth over the forecast period due to rising respiratory infections and disorders.

Q6. In breathing disorder & treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period due to increasing geriatric population and rising cases of respiratory disorders in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breathing disorder & treatment market by type (antibiotics, non-steroidal anti-inflammatory drug (NSAIDs), cough suppressant, nasal decongestant, and others), indication (chronic obstructive pulmonary disease (COPD), asthma, allergic rhinitis, pulmonary hypertension, cystic fibrosis (CF), idiopathic pulmonary fibrosis, and others), end use (hospital and clinics, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breathing Disorder & Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breathing Disorder & Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breathing Disorder & Treatment Market by Type
    • 3.3.1: Antibiotics
    • 3.3.2: Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
    • 3.3.3: Cough Suppressant
    • 3.3.4: Nasal Decongestant
    • 3.3.5: Others
  • 3.4: Global Breathing Disorder & Treatment Market by Indication
    • 3.4.1: Chronic Obstructive Pulmonary Disease (COPD)
    • 3.4.2: Asthma
    • 3.4.3: Allergic Rhinitis
    • 3.4.4: Pulmonary Hypertension
    • 3.4.5: Cystic Fibrosis (CF)
    • 3.4.6: Idiopathic Pulmonary Fibrosis
    • 3.4.7: Others
  • 3.5: Global Breathing Disorder & Treatment Market by End Use
    • 3.5.1: Hospital and Clinics
    • 3.5.2: Retail Pharmacies
    • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breathing Disorder & Treatment Market by Region
  • 4.2: North American Breathing Disorder & Treatment Market
    • 4.2.1: North American Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.2.2: North American Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies
  • 4.3: European Breathing Disorder & Treatment Market
    • 4.3.1: European Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.3.2: European Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies
  • 4.4: APAC Breathing Disorder & Treatment Market
    • 4.4.1: APAC Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.4.2 APAC Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies
  • 4.5: ROW Breathing Disorder & Treatment Market
    • 4.5.1: ROW Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.5.2: ROW Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breathing Disorder & Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Breathing Disorder & Treatment Market by Indication
    • 6.1.3: Growth Opportunities for the Global Breathing Disorder & Treatment Market by End Use
    • 6.1.4: Growth Opportunities for the Global Breathing Disorder & Treatment Market by Region
  • 6.2: Emerging Trends in the Global Breathing Disorder & Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breathing Disorder & Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breathing Disorder & Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AstraZeneca
  • 7.2: GlaxoSmithKline
  • 7.3: Merck Sharp & Dohme
  • 7.4: Abbott
  • 7.5: Medtronic
  • 7.6: Hoffmann-La Roche
  • 7.7: Novartis